NFE2L2 and familial dilated cardiomyopathy: This suggests that spiraeoside may protect against DCM by activating the PI3K/Akt/Nrf2 signaling pathway, alleviating high-glucose-induced cardiomyocyte oxidative stress, cellular damage, and apoptosis (Liu H. Y. et al., 2020).